Abstract
Objectives/Methods: Placebo-controlled phase II study evaluated aspirin’s effect on CDX2 mRNA and prostanoid production in native and neosquamous epithelium after successful radiofrequency ablation (RFA) in Barrett’s esophagus. Results: At 12 months TXB2, PGF2α, PGD2, PGE2, PGE1, and α13PGE2 increased in native squamous but not neosquamous epithelium in individuals randomized to placebo. Aspirin use significantly reduced CDX2 mRNA in native squamous epithelium, and was associated with decreases in PGE1, PGE2 and 13PGE2 in neosquamous epithelium. Conclusions: After RFA, native squamous and neosquamous epithelium exhibit different molecular markers and responses to aspirin suggesting that different sources of squamous progenitors contribute to esophageal re-epithelization.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1034-1042 |
| Number of pages | 9 |
| Journal | Digestive Diseases and Sciences |
| Volume | 70 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 2025 |
Keywords
- Barrett’s esophagus
- CDX2
- Chemoprevention
- Eicosanoids
- Radiofrequency ablation
ASJC Scopus subject areas
- Physiology
- Gastroenterology
Fingerprint
Dive into the research topics of 'Effect of Aspirin on Biomarkers of Barrett’s Esophagus After Successful Eradication with Radiofrequency Ablation'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS